Table 1 Baseline patient characteristics.

From: Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Median age (range)

58 (45–77)

Stage

 

 IIIC

16

 IV

3

Histotype

 

 High-grade serous

18

 Mixed

1

Primary

 

 Ovary

16

 Fallopian tube

2

 Peritoneum

1

Neoadjuvant chemotherapy

 

 No

14

 Yes

5

Debulking status

 

 Primary, R0

9

 Primary, <1 cm

4

 Primary, >1 cm

1

 Interval, R0

5

Median cycles of chemotherapy (range)

6 (6–9)